Why Science? | A*STAR Infectious Diseases Labs

A*STAR lists vector-borne disease, respiratory disease, antimicrobial resistance and preparedness or outbreak response as cross-cutting programmes. These areas share surveillance, pathogen, immune and translational methods. Each claim should identify its disease system and official programme.

Infectious-disease science connects pathogen, host, environment and time; leaving out any layer can change the explanation. The practical capability is institutional literacy. Keep the source, method, calibration or control, uncertainty, review and next decision in one evidence receipt. That record makes progress visible without enlarging the claim beyond the measurement. A*STAR IDL and authorised collaborators control current studies and facilities; healthcare and public-health authorities, biosafety bodies and regulators control outbreak decisions and clinical use.

Put this into practice by turning the idea into a small, reviewable action: Build a dated evidence card for “IDL organises four connected research programmes” with a source, method, observation, limitation and next test. Then ask what the resulting note or artefact actually demonstrates. A useful record names context, source or instruction, action, observation, interpretation and uncertainty. It also preserves this limit: The institute mission does not prove a specific intervention works.

An evidence check keeps confidence proportional to what the work can show. Separate the original observation or official statement from the learner’s explanation. Record feedback and any revision. If information is missing, write “not shown” or “not yet known” rather than guessing. That honest gap can become the next question.

Contents · Next chapter

Disease depends on the organism, route, dose, host response and tissue environment. Colonisation, infection and symptoms are different states. Research separates these stages so a detected microbe is not treated as a complete explanation.

Preparedness earns value before a crisis through surveillance, validated assays, trained teams, safe facilities and rehearsed decisions. The practical capability is host-pathogen reasoning. Keep the source, method, calibration or control, uncertainty, review and next decision in one evidence receipt. That record makes progress visible without enlarging the claim beyond the measurement. A*STAR IDL and authorised collaborators control current studies and facilities; healthcare and public-health authorities, biosafety bodies and regulators control outbreak decisions and clinical use.

Put this into practice by turning the idea into a small, reviewable action: Build a dated evidence card for “Infection begins with a host–pathogen encounter” with a source, method, observation, limitation and next test. Then ask what the resulting note or artefact actually demonstrates. A useful record names context, source or instruction, action, observation, interpretation and uncertainty. It also preserves this limit: Detection does not establish disease severity or causation by itself.

An evidence check keeps confidence proportional to what the work can show. Separate the original observation or official statement from the learner’s explanation. Record feedback and any revision. If information is missing, write “not shown” or “not yet known” rather than guessing. That honest gap can become the next question.

Contents · Previous chapter · Next chapter

Pathogens may move through droplets, contact, food, water, vectors or other routes. Infectious period, behaviour and environment shape spread. Control measures work on particular links and should be evaluated for the setting.

Resistance and evolution make yesterday’s evidence provisional, so sampling dates, lineages and treatment context must stay visible. The practical capability is transmission literacy. Keep the source, method, calibration or control, uncertainty, review and next decision in one evidence receipt. That record makes progress visible without enlarging the claim beyond the measurement. A*STAR IDL and authorised collaborators control current studies and facilities; healthcare and public-health authorities, biosafety bodies and regulators control outbreak decisions and clinical use.

Put this into practice by turning the idea into a small, reviewable action: Build a dated evidence card for “Transmission is a chain with breakable links” with a source, method, observation, limitation and next test. Then ask what the resulting note or artefact actually demonstrates. A useful record names context, source or instruction, action, observation, interpretation and uncertainty. It also preserves this limit: A plausible route is not proof of who infected whom.

An evidence check keeps confidence proportional to what the work can show. Separate the original observation or official statement from the learner’s explanation. Record feedback and any revision. If information is missing, write “not shown” or “not yet known” rather than guessing. That honest gap can become the next question.

Contents · Previous chapter · Next chapter

Clinical, laboratory and genomic surveillance can reveal unusual disease patterns. Sampling coverage, case definitions and reporting delay affect what the system sees. Trends need denominators and context before interpretation.

High-containment research is possible only through engineered controls, training, governance and a culture that treats safety evidence as part of the science. The practical capability is surveillance design. Keep the source, method, calibration or control, uncertainty, review and next decision in one evidence receipt. That record makes progress visible without enlarging the claim beyond the measurement. A*STAR IDL and authorised collaborators control current studies and facilities; healthcare and public-health authorities, biosafety bodies and regulators control outbreak decisions and clinical use.

Put this into practice by turning the idea into a small, reviewable action: Build a dated evidence card for “Surveillance turns samples into an early-warning system” with a source, method, observation, limitation and next test. Then ask what the resulting note or artefact actually demonstrates. A useful record names context, source or instruction, action, observation, interpretation and uncertainty. It also preserves this limit: A rise in detections may reflect more testing rather than more disease.

An evidence check keeps confidence proportional to what the work can show. Separate the original observation or official statement from the learner’s explanation. Record feedback and any revision. If information is missing, write “not shown” or “not yet known” rather than guessing. That honest gap can become the next question.

Contents · Previous chapter · Next chapter

A test for screening, confirmation or treatment guidance faces different accuracy and timing needs. Sensitivity, specificity and predictive value depend on prevalence and population. Specimen collection and reference standards belong in evaluation.

Infectious-disease science connects pathogen, host, environment and time; leaving out any layer can change the explanation. The practical capability is diagnostic evaluation. Keep the source, method, calibration or control, uncertainty, review and next decision in one evidence receipt. That record makes progress visible without enlarging the claim beyond the measurement. A*STAR IDL and authorised collaborators control current studies and facilities; healthcare and public-health authorities, biosafety bodies and regulators control outbreak decisions and clinical use.

Put this into practice by turning the idea into a small, reviewable action: Build a dated evidence card for “Diagnostics need the right intended use” with a source, method, observation, limitation and next test. Then ask what the resulting note or artefact actually demonstrates. A useful record names context, source or instruction, action, observation, interpretation and uncertainty. It also preserves this limit: A positive research assay is not personal diagnosis.

An evidence check keeps confidence proportional to what the work can show. Separate the original observation or official statement from the learner’s explanation. Record feedback and any revision. If information is missing, write “not shown” or “not yet known” rather than guessing. That honest gap can become the next question.

Contents · Previous chapter · Next chapter

Pathogen sequences can reveal lineages, mutations and relatedness. Evolutionary trees depend on sampling and models. Epidemiological evidence is needed before inferring direct transmission or public-health significance.

Preparedness earns value before a crisis through surveillance, validated assays, trained teams, safe facilities and rehearsed decisions. The practical capability is genomic epidemiology. Keep the source, method, calibration or control, uncertainty, review and next decision in one evidence receipt. That record makes progress visible without enlarging the claim beyond the measurement. A*STAR IDL and authorised collaborators control current studies and facilities; healthcare and public-health authorities, biosafety bodies and regulators control outbreak decisions and clinical use.

Put this into practice by turning the idea into a small, reviewable action: Build a dated evidence card for “Genomic epidemiology tracks change” with a source, method, observation, limitation and next test. Then ask what the resulting note or artefact actually demonstrates. A useful record names context, source or instruction, action, observation, interpretation and uncertainty. It also preserves this limit: Sequence similarity alone cannot identify a direct transmission event.

An evidence check keeps confidence proportional to what the work can show. Separate the original observation or official statement from the learner’s explanation. Record feedback and any revision. If information is missing, write “not shown” or “not yet known” rather than guessing. That honest gap can become the next question.

Contents · Previous chapter · Next chapter

Mosquitoes and other vectors interact with pathogens, people, climate and habitats. Laboratory competence and field transmission are different questions. Integrated evidence guides surveillance and control without blaming one environmental factor.

Resistance and evolution make yesterday’s evidence provisional, so sampling dates, lineages and treatment context must stay visible. The practical capability is disease ecology. Keep the source, method, calibration or control, uncertainty, review and next decision in one evidence receipt. That record makes progress visible without enlarging the claim beyond the measurement. A*STAR IDL and authorised collaborators control current studies and facilities; healthcare and public-health authorities, biosafety bodies and regulators control outbreak decisions and clinical use.

Put this into practice by turning the idea into a small, reviewable action: Build a dated evidence card for “Vector-borne disease includes an ecology” with a source, method, observation, limitation and next test. Then ask what the resulting note or artefact actually demonstrates. A useful record names context, source or instruction, action, observation, interpretation and uncertainty. It also preserves this limit: A climate association does not fully predict local transmission.

An evidence check keeps confidence proportional to what the work can show. Separate the original observation or official statement from the learner’s explanation. Record feedback and any revision. If information is missing, write “not shown” or “not yet known” rather than guessing. That honest gap can become the next question.

Contents · Previous chapter · Next chapter

IDL studies respiratory pathogens including mycobacteria and coronaviruses through microbiology, immunology, models and clinical cohorts. Lung damage may reflect both infection and host inflammation. Timing changes which mechanism dominates.

High-containment research is possible only through engineered controls, training, governance and a culture that treats safety evidence as part of the science. The practical capability is respiratory-infection biology. Keep the source, method, calibration or control, uncertainty, review and next decision in one evidence receipt. That record makes progress visible without enlarging the claim beyond the measurement. A*STAR IDL and authorised collaborators control current studies and facilities; healthcare and public-health authorities, biosafety bodies and regulators control outbreak decisions and clinical use.

Put this into practice by turning the idea into a small, reviewable action: Build a dated evidence card for “Respiratory disease spans pathogen and tissue response” with a source, method, observation, limitation and next test. Then ask what the resulting note or artefact actually demonstrates. A useful record names context, source or instruction, action, observation, interpretation and uncertainty. It also preserves this limit: A result from one model or disease stage may not generalise.

An evidence check keeps confidence proportional to what the work can show. Separate the original observation or official statement from the learner’s explanation. Record feedback and any revision. If information is missing, write “not shown” or “not yet known” rather than guessing. That honest gap can become the next question.

Contents · Previous chapter · Next chapter

Microbes vary, and antimicrobial exposure can favour resistant populations. Resistance genes, drug concentration, transmission and infection control all matter. Susceptibility testing and surveillance must use current standards.

Infectious-disease science connects pathogen, host, environment and time; leaving out any layer can change the explanation. The practical capability is AMR literacy. Keep the source, method, calibration or control, uncertainty, review and next decision in one evidence receipt. That record makes progress visible without enlarging the claim beyond the measurement. A*STAR IDL and authorised collaborators control current studies and facilities; healthcare and public-health authorities, biosafety bodies and regulators control outbreak decisions and clinical use.

Put this into practice by turning the idea into a small, reviewable action: Build a dated evidence card for “Antimicrobial resistance evolves under selection” with a source, method, observation, limitation and next test. Then ask what the resulting note or artefact actually demonstrates. A useful record names context, source or instruction, action, observation, interpretation and uncertainty. It also preserves this limit: Laboratory resistance does not alone determine an individual treatment.

An evidence check keeps confidence proportional to what the work can show. Separate the original observation or official statement from the learner’s explanation. Record feedback and any revision. If information is missing, write “not shown” or “not yet known” rather than guessing. That honest gap can become the next question.

Contents · Previous chapter · Next chapter

Antimicrobial use and resistant organisms connect humans, animals, food and environment. Evidence should trace pathways rather than assume that presence in two places proves movement between them. Coordinated stewardship addresses several links.

Preparedness earns value before a crisis through surveillance, validated assays, trained teams, safe facilities and rehearsed decisions. The practical capability is One Health reasoning. Keep the source, method, calibration or control, uncertainty, review and next decision in one evidence receipt. That record makes progress visible without enlarging the claim beyond the measurement. A*STAR IDL and authorised collaborators control current studies and facilities; healthcare and public-health authorities, biosafety bodies and regulators control outbreak decisions and clinical use.

Put this into practice by turning the idea into a small, reviewable action: Build a dated evidence card for “One Health widens the resistance question” with a source, method, observation, limitation and next test. Then ask what the resulting note or artefact actually demonstrates. A useful record names context, source or instruction, action, observation, interpretation and uncertainty. It also preserves this limit: Shared resistance markers do not prove a direction of transfer.

An evidence check keeps confidence proportional to what the work can show. Separate the original observation or official statement from the learner’s explanation. Record feedback and any revision. If information is missing, write “not shown” or “not yet known” rather than guessing. That honest gap can become the next question.

Contents · Previous chapter · Next chapter

IDL describes antibodies, phages, synthetic antimicrobials, RNA delivery and host-targeted approaches. Each needs identity, mechanism, dose, resistance risk and safety evidence. Early activity narrows candidates rather than producing a treatment.

Resistance and evolution make yesterday’s evidence provisional, so sampling dates, lineages and treatment context must stay visible. The practical capability is anti-infective discovery. Keep the source, method, calibration or control, uncertainty, review and next decision in one evidence receipt. That record makes progress visible without enlarging the claim beyond the measurement. A*STAR IDL and authorised collaborators control current studies and facilities; healthcare and public-health authorities, biosafety bodies and regulators control outbreak decisions and clinical use.

Put this into practice by turning the idea into a small, reviewable action: Build a dated evidence card for “Therapeutic discovery tests several strategies” with a source, method, observation, limitation and next test. Then ask what the resulting note or artefact actually demonstrates. A useful record names context, source or instruction, action, observation, interpretation and uncertainty. It also preserves this limit: In-vitro activity is not clinical efficacy.

An evidence check keeps confidence proportional to what the work can show. Separate the original observation or official statement from the learner’s explanation. Record feedback and any revision. If information is missing, write “not shown” or “not yet known” rather than guessing. That honest gap can become the next question.

Contents · Previous chapter · Next chapter

Vaccine research joins antigen design, formulation, immune response, manufacturing, trials and monitoring. Correlates may support development when validated. Protection and safety claims belong to authorised clinical evidence.

High-containment research is possible only through engineered controls, training, governance and a culture that treats safety evidence as part of the science. The practical capability is vaccine evidence literacy. Keep the source, method, calibration or control, uncertainty, review and next decision in one evidence receipt. That record makes progress visible without enlarging the claim beyond the measurement. A*STAR IDL and authorised collaborators control current studies and facilities; healthcare and public-health authorities, biosafety bodies and regulators control outbreak decisions and clinical use.

Put this into practice by turning the idea into a small, reviewable action: Build a dated evidence card for “Vaccines require layered evidence” with a source, method, observation, limitation and next test. Then ask what the resulting note or artefact actually demonstrates. A useful record names context, source or instruction, action, observation, interpretation and uncertainty. It also preserves this limit: An immune marker is not automatically proven protection.

An evidence check keeps confidence proportional to what the work can show. Separate the original observation or official statement from the learner’s explanation. Record feedback and any revision. If information is missing, write “not shown” or “not yet known” rather than guessing. That honest gap can become the next question.

Contents · Previous chapter · Next chapter

Cells, organoids, animals and microfluidic systems can isolate questions that cannot be tested directly in people. Each model represents selected features. Findings need transfer checks with human data.

Infectious-disease science connects pathogen, host, environment and time; leaving out any layer can change the explanation. The practical capability is model validity. Keep the source, method, calibration or control, uncertainty, review and next decision in one evidence receipt. That record makes progress visible without enlarging the claim beyond the measurement. A*STAR IDL and authorised collaborators control current studies and facilities; healthcare and public-health authorities, biosafety bodies and regulators control outbreak decisions and clinical use.

Put this into practice by turning the idea into a small, reviewable action: Build a dated evidence card for “Models let experiments challenge mechanisms” with a source, method, observation, limitation and next test. Then ask what the resulting note or artefact actually demonstrates. A useful record names context, source or instruction, action, observation, interpretation and uncertainty. It also preserves this limit: Preclinical success does not guarantee human benefit.

An evidence check keeps confidence proportional to what the work can show. Separate the original observation or official statement from the learner’s explanation. Record feedback and any revision. If information is missing, write “not shown” or “not yet known” rather than guessing. That honest gap can become the next question.

Contents · Previous chapter · Next chapter

A*STAR’s high-containment platform combines facility design, procedures, training, oversight and monitoring. Risk assessment determines authorised work and controls. Safety records and incident learning are part of research quality.

Preparedness earns value before a crisis through surveillance, validated assays, trained teams, safe facilities and rehearsed decisions. The practical capability is biosafety literacy. Keep the source, method, calibration or control, uncertainty, review and next decision in one evidence receipt. That record makes progress visible without enlarging the claim beyond the measurement. A*STAR IDL and authorised collaborators control current studies and facilities; healthcare and public-health authorities, biosafety bodies and regulators control outbreak decisions and clinical use.

Put this into practice by turning the idea into a small, reviewable action: Build a dated evidence card for “High containment is an engineered safety system” with a source, method, observation, limitation and next test. Then ask what the resulting note or artefact actually demonstrates. A useful record names context, source or instruction, action, observation, interpretation and uncertainty. It also preserves this limit: Technical capability does not authorise unsupervised pathogen work.

An evidence check keeps confidence proportional to what the work can show. Separate the original observation or official statement from the learner’s explanation. Record feedback and any revision. If information is missing, write “not shown” or “not yet known” rather than guessing. That honest gap can become the next question.

Contents · Previous chapter · Next chapter

Preparedness connects assays, models, countermeasure research and partnerships to response frameworks. Exercises should reveal bottlenecks before emergencies. Roles, thresholds and communication need current owners.

Resistance and evolution make yesterday’s evidence provisional, so sampling dates, lineages and treatment context must stay visible. The practical capability is preparedness systems thinking. Keep the source, method, calibration or control, uncertainty, review and next decision in one evidence receipt. That record makes progress visible without enlarging the claim beyond the measurement. A*STAR IDL and authorised collaborators control current studies and facilities; healthcare and public-health authorities, biosafety bodies and regulators control outbreak decisions and clinical use.

Put this into practice by turning the idea into a small, reviewable action: Build a dated evidence card for “Preparedness joins science with decisions” with a source, method, observation, limitation and next test. Then ask what the resulting note or artefact actually demonstrates. A useful record names context, source or instruction, action, observation, interpretation and uncertainty. It also preserves this limit: A research forecast does not replace public-health authority.

An evidence check keeps confidence proportional to what the work can show. Separate the original observation or official statement from the learner’s explanation. Record feedback and any revision. If information is missing, write “not shown” or “not yet known” rather than guessing. That honest gap can become the next question.

Contents · Previous chapter · Next chapter

Relevant pathways span microbiology, immunology, epidemiology, genomics, engineering, data science, biosafety and communication. Students can use safe public datasets or simulations. Institutions control high-containment access and professional practice.

High-containment research is possible only through engineered controls, training, governance and a culture that treats safety evidence as part of the science. The practical capability is infectious-disease career preparation. Keep the source, method, calibration or control, uncertainty, review and next decision in one evidence receipt. That record makes progress visible without enlarging the claim beyond the measurement. A*STAR IDL and authorised collaborators control current studies and facilities; healthcare and public-health authorities, biosafety bodies and regulators control outbreak decisions and clinical use.

Put this into practice by turning the idea into a small, reviewable action: Build a dated evidence card for “Students can combine laboratory and public-health skills” with a source, method, observation, limitation and next test. Then ask what the resulting note or artefact actually demonstrates. A useful record names context, source or instruction, action, observation, interpretation and uncertainty. It also preserves this limit: A classroom exercise does not qualify anyone to handle pathogens.

An evidence check keeps confidence proportional to what the work can show. Separate the original observation or official statement from the learner’s explanation. Record feedback and any revision. If information is missing, write “not shown” or “not yet known” rather than guessing. That honest gap can become the next question.

Contents · Previous chapter · Next chapter

Archive case definition, sample and time, assay and controls, sequence, cohort, model, uncertainty, biosafety approval, intervention evidence, decision owner and updated protocol. This lineage separates scientific signal from authorised response.

Infectious-disease science connects pathogen, host, environment and time; leaving out any layer can change the explanation. The practical capability is evidence governance. Keep the source, method, calibration or control, uncertainty, review and next decision in one evidence receipt. That record makes progress visible without enlarging the claim beyond the measurement. A*STAR IDL and authorised collaborators control current studies and facilities; healthcare and public-health authorities, biosafety bodies and regulators control outbreak decisions and clinical use.

Put this into practice by turning the idea into a small, reviewable action: Build a dated evidence card for “Keep an outbreak evidence receipt” with a source, method, observation, limitation and next test. Then ask what the resulting note or artefact actually demonstrates. A useful record names context, source or instruction, action, observation, interpretation and uncertainty. It also preserves this limit: The latest official surveillance and public-health guidance control action.

An evidence check keeps confidence proportional to what the work can show. Separate the original observation or official statement from the learner’s explanation. Record feedback and any revision. If information is missing, write “not shown” or “not yet known” rather than guessing. That honest gap can become the next question.

Contents · Previous chapter